WallStreetZenWallStreetZen

NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattChairperson CEO2025-12-121,100$489.95
$538.95kSell
Martine A. RothblattChairperson CEO2025-12-124,000$120.26
$481.04kBuy
Martine A. RothblattChairperson CEO2025-12-122,900$490.98
$1.42MSell
Martine A. RothblattChairperson CEO2025-12-111,500$483.12
$724.68kSell
Martine A. RothblattChairperson CEO2025-12-114,000$120.26
$481.04kBuy
Paul A. MahonEVP GENERAL COUNSEL2025-12-1111,000$146.03
$1.61MBuy
Martine A. RothblattChairperson CEO2025-12-11524$485.14
$254.21kSell
Martine A. RothblattChairperson CEO2025-12-111,976$484.30
$956.98kSell
Paul A. MahonEVP GENERAL COUNSEL2025-12-111,116$486.36
$542.78kSell
Paul A. MahonEVP GENERAL COUNSEL2025-12-112,804$485.22
$1.36MSell

1 of 93

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.43%5,352,996$2.64BInstitution
Lilly Co Eli12.20%5,251,394$2.59BInsider
Vanguard Group Inc10.26%4,418,610$2.18BInstitution
Renaissance Technologies LLC5.05%2,173,392$1.07BInstitution
Avoro Capital Advisors LLC4.70%2,022,222$998.96MInstitution
State Street Corp4.47%1,922,609$949.75MInstitution
Wellington Management Group LLP3.25%1,398,781$690.98MInstitution
Geode Capital Management LLC2.90%1,249,660$617.32MInstitution
Aqr Capital Management LLC2.29%986,478$487.31MInstitution
Martine A. Rothblatt1.95%838,072$414.00MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.70%13.30%Net SellingNet Selling
RPRX56.76%17.37%Net SellingNet Selling
GMAB96.17%0.00%
BNTX20.98%0.00%
INCY77.68%22.32%Net SellingNet Selling
View Top Biotech Stocks

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 94.92% institutional shareholders, 14.56% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.59B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.